Quantum-Si incorporated (NASDAQ: QSI) Stock Competitors & Peer Comparison

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while BSX-PA trades at $122.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, QSI's ROE is -0.47%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, QSI is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for QSI.Check BSX-PA's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, ABT has a market cap of 175.3B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while ABT trades at $101.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas ABT's P/E ratio is 19.44. In terms of profitability, QSI's ROE is -0.47%, compared to ABT's ROE of +0.11%. Regarding short-term risk, QSI is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for QSI.Check ABT's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, MDT has a market cap of 113.5B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while MDT trades at $88.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas MDT's P/E ratio is 16.03. In terms of profitability, QSI's ROE is -0.47%, compared to MDT's ROE of +0.11%. Regarding short-term risk, QSI is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for QSI.Check MDT's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, SYK has a market cap of 104.5B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while SYK trades at $272.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas SYK's P/E ratio is 20.35. In terms of profitability, QSI's ROE is -0.47%, compared to SYK's ROE of +0.16%. Regarding short-term risk, QSI is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for QSI.Check SYK's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, BSX has a market cap of 65.3B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while BSX trades at $43.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas BSX's P/E ratio is 14.17. In terms of profitability, QSI's ROE is -0.47%, compared to BSX's ROE of +0.15%. Regarding short-term risk, QSI is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for QSI.Check BSX's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, EW has a market cap of 49.7B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while EW trades at $86.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas EW's P/E ratio is 31.96. In terms of profitability, QSI's ROE is -0.47%, compared to EW's ROE of +0.10%. Regarding short-term risk, QSI is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for QSI.Check EW's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, DXCM has a market cap of 32.7B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while DXCM trades at $86.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas DXCM's P/E ratio is 33.97. In terms of profitability, QSI's ROE is -0.47%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, QSI is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for QSI.Check DXCM's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, GEHC has a market cap of 30.1B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while GEHC trades at $66.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas GEHC's P/E ratio is 14.61. In terms of profitability, QSI's ROE is -0.47%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, QSI is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for QSI.Check GEHC's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, PHG has a market cap of 24.4B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while PHG trades at $24.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas PHG's P/E ratio is 14.26. In terms of profitability, QSI's ROE is -0.47%, compared to PHG's ROE of +0.10%. Regarding short-term risk, QSI is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for QSI.Check PHG's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, ZBH has a market cap of 17.6B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while ZBH trades at $91.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas ZBH's P/E ratio is 10.73. In terms of profitability, QSI's ROE is -0.47%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, QSI is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for QSI.Check ZBH's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while ABMD trades at $381.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas ABMD's P/E ratio is 65.36. In terms of profitability, QSI's ROE is -0.47%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, QSI is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for QSI.Check ABMD's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while SWAV trades at $334.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas SWAV's P/E ratio is 78.76. In terms of profitability, QSI's ROE is -0.47%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, QSI is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for QSI.Check SWAV's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while PEN trades at $318.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas PEN's P/E ratio is 83.25. In terms of profitability, QSI's ROE is -0.47%, compared to PEN's ROE of +0.11%. Regarding short-term risk, QSI is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for QSI.Check PEN's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, SNN has a market cap of 11.3B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while SNN trades at $26.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas SNN's P/E ratio is 18.17. In terms of profitability, QSI's ROE is -0.47%, compared to SNN's ROE of +0.12%. Regarding short-term risk, QSI is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for QSI.Check SNN's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, BIO-B has a market cap of 10.5B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while BIO-B trades at $385.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas BIO-B's P/E ratio is -67.89. In terms of profitability, QSI's ROE is -0.47%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, QSI is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for QSI.Check BIO-B's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, ALGN has a market cap of 10.5B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while ALGN trades at $146.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas ALGN's P/E ratio is 13.38. In terms of profitability, QSI's ROE is -0.47%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, QSI is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for QSI.Check ALGN's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, BIO has a market cap of 10.3B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while BIO trades at $381.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas BIO's P/E ratio is 41.05. In terms of profitability, QSI's ROE is -0.47%, compared to BIO's ROE of +0.03%. Regarding short-term risk, QSI is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for QSI.Check BIO's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, GMED has a market cap of 10.1B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while GMED trades at $74.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas GMED's P/E ratio is 16.79. In terms of profitability, QSI's ROE is -0.47%, compared to GMED's ROE of +0.12%. Regarding short-term risk, QSI is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for QSI.Check GMED's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, BRKR has a market cap of 9.8B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while BRKR trades at $64.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas BRKR's P/E ratio is 32.25. In terms of profitability, QSI's ROE is -0.47%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, QSI is more volatile compared to BRKR. This indicates higher risk in terms of short-term price fluctuations for QSI.Check BRKR's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, BRKRP has a market cap of 9.4B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while BRKRP trades at $470.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas BRKRP's P/E ratio is 255.66. In terms of profitability, QSI's ROE is -0.47%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, QSI is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for QSI.Check BRKRP's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, PODD has a market cap of 9.4B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while PODD trades at $136.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas PODD's P/E ratio is 23.19. In terms of profitability, QSI's ROE is -0.47%, compared to PODD's ROE of +0.27%. Regarding short-term risk, QSI is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for QSI.Check PODD's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while MASI trades at $179.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas MASI's P/E ratio is 44.43. In terms of profitability, QSI's ROE is -0.47%, compared to MASI's ROE of +0.09%. Regarding short-term risk, QSI is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for QSI.Check MASI's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, GKOS has a market cap of 9.1B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while GKOS trades at $154.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas GKOS's P/E ratio is -180.02. In terms of profitability, QSI's ROE is -0.47%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, QSI is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for QSI.Check GKOS's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, HAE has a market cap of 4.8B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while HAE trades at $105.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas HAE's P/E ratio is 21.02. In terms of profitability, QSI's ROE is -0.47%, compared to HAE's ROE of +0.11%. Regarding short-term risk, QSI is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for QSI.Check HAE's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while NARI trades at $79.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas NARI's P/E ratio is -59.24. In terms of profitability, QSI's ROE is -0.47%, compared to NARI's ROE of -0.00%. Regarding short-term risk, QSI is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for QSI.Check NARI's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while ITGR trades at $126.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas ITGR's P/E ratio is 19.89. In terms of profitability, QSI's ROE is -0.47%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, QSI is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for QSI.Check ITGR's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, LIVN has a market cap of 4.2B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while LIVN trades at $76.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas LIVN's P/E ratio is 18.20. In terms of profitability, QSI's ROE is -0.47%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, QSI is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for QSI.Check LIVN's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while AXNX trades at $70.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas AXNX's P/E ratio is -709.80. In terms of profitability, QSI's ROE is -0.47%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, QSI is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for QSI.Check AXNX's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, IRTC has a market cap of 3.6B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while IRTC trades at $110.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas IRTC's P/E ratio is -256.70. In terms of profitability, QSI's ROE is -0.47%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, QSI is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for QSI.Check IRTC's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, NEOG has a market cap of 3B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while NEOG trades at $13.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas NEOG's P/E ratio is 49.14. In terms of profitability, QSI's ROE is -0.47%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, QSI is more volatile compared to NEOG. This indicates higher risk in terms of short-term price fluctuations for QSI.Check NEOG's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, TMDX has a market cap of 2.9B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while TMDX trades at $85.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas TMDX's P/E ratio is 43.29. In terms of profitability, QSI's ROE is -0.47%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, QSI is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for QSI.Check TMDX's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, BFLY has a market cap of 2.5B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while BFLY trades at $9.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas BFLY's P/E ratio is -39.13. In terms of profitability, QSI's ROE is -0.47%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, QSI is more volatile compared to BFLY. This indicates higher risk in terms of short-term price fluctuations for QSI.Check BFLY's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, AXGN has a market cap of 2.3B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while AXGN trades at $43.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas AXGN's P/E ratio is 114.18. In terms of profitability, QSI's ROE is -0.47%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, QSI is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for QSI.Check AXGN's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while UFPT trades at $295.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas UFPT's P/E ratio is 30.20. In terms of profitability, QSI's ROE is -0.47%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, QSI is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for QSI.Check UFPT's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while NUVA trades at $39.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas NUVA's P/E ratio is 75.00. In terms of profitability, QSI's ROE is -0.47%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, QSI is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for QSI.Check NUVA's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, INSP has a market cap of 2B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while INSP trades at $70.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas INSP's P/E ratio is 31.06. In terms of profitability, QSI's ROE is -0.47%, compared to INSP's ROE of +0.18%. Regarding short-term risk, QSI is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for QSI.Check INSP's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, ESTA has a market cap of 1.9B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while ESTA trades at $65.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas ESTA's P/E ratio is -52.36. In terms of profitability, QSI's ROE is -0.47%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, QSI is more volatile compared to ESTA. This indicates higher risk in terms of short-term price fluctuations for QSI.Check ESTA's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, NVCR has a market cap of 1.8B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while NVCR trades at $15.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas NVCR's P/E ratio is -12.18. In terms of profitability, QSI's ROE is -0.47%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, QSI is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for QSI.Check NVCR's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, ATEC has a market cap of 1.6B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while ATEC trades at $10.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas ATEC's P/E ratio is -168.67. In terms of profitability, QSI's ROE is -0.47%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, QSI is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for QSI.Check ATEC's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while CNMD trades at $45.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas CNMD's P/E ratio is 9.97. In terms of profitability, QSI's ROE is -0.47%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, QSI is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for QSI.Check CNMD's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while HSKA trades at $119.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas HSKA's P/E ratio is -62.49. In terms of profitability, QSI's ROE is -0.47%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, QSI is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for QSI.Check HSKA's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while IART trades at $16.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas IART's P/E ratio is 6.83. In terms of profitability, QSI's ROE is -0.47%, compared to IART's ROE of -0.01%. Regarding short-term risk, QSI is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for QSI.Check IART's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while AVNS trades at $24.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas AVNS's P/E ratio is 27.77. In terms of profitability, QSI's ROE is -0.47%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, QSI is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for QSI.Check AVNS's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while SILK trades at $27.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas SILK's P/E ratio is -18.96. In terms of profitability, QSI's ROE is -0.47%, compared to SILK's ROE of -0.35%. Regarding short-term risk, QSI is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for QSI.Check SILK's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while AORT trades at $22.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas AORT's P/E ratio is 37.75. In terms of profitability, QSI's ROE is -0.47%, compared to AORT's ROE of -0.01%. Regarding short-term risk, QSI is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for QSI.Check AORT's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while FNA trades at $13.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas FNA's P/E ratio is -19.83. In terms of profitability, QSI's ROE is -0.47%, compared to FNA's ROE of -0.35%. Regarding short-term risk, QSI is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for QSI.Check FNA's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while IRMD trades at $85.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas IRMD's P/E ratio is 43.10. In terms of profitability, QSI's ROE is -0.47%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, QSI is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for QSI.Check IRMD's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, TNDM has a market cap of 1.1B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while TNDM trades at $15.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas TNDM's P/E ratio is -16.90. In terms of profitability, QSI's ROE is -0.47%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, QSI is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for QSI.Check TNDM's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, ENOV has a market cap of 1.1B. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while ENOV trades at $18.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas ENOV's P/E ratio is 5.29. In terms of profitability, QSI's ROE is -0.47%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, QSI is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for QSI.Check ENOV's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, LMRI has a market cap of 981M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while LMRI trades at $10.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas LMRI's P/E ratio is -19.86. In terms of profitability, QSI's ROE is -0.47%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, QSI is more volatile compared to LMRI. This indicates higher risk in terms of short-term price fluctuations for QSI.Check LMRI's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, PRCT has a market cap of 979M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while PRCT trades at $17.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas PRCT's P/E ratio is -8.87. In terms of profitability, QSI's ROE is -0.47%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, QSI is more volatile compared to PRCT. This indicates higher risk in terms of short-term price fluctuations for QSI.Check PRCT's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, BBNX has a market cap of 967.7M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while BBNX trades at $21.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas BBNX's P/E ratio is -13.04. In terms of profitability, QSI's ROE is -0.47%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, QSI is more volatile compared to BBNX. This indicates higher risk in terms of short-term price fluctuations for QSI.Check BBNX's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, BVS has a market cap of 935.6M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while BVS trades at $13.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas BVS's P/E ratio is 18.17. In terms of profitability, QSI's ROE is -0.47%, compared to BVS's ROE of +0.28%. Regarding short-term risk, QSI is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for QSI.Check BVS's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, CBLL has a market cap of 898.9M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while CBLL trades at $23.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas CBLL's P/E ratio is -13.46. In terms of profitability, QSI's ROE is -0.47%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, QSI is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for QSI.Check CBLL's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while CSII trades at $20.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas CSII's P/E ratio is -20.83. In terms of profitability, QSI's ROE is -0.47%, compared to CSII's ROE of -0.14%. Regarding short-term risk, QSI is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for QSI.Check CSII's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, SIBN has a market cap of 824.5M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while SIBN trades at $18.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas SIBN's P/E ratio is -54.68. In terms of profitability, QSI's ROE is -0.47%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, QSI is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for QSI.Check SIBN's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, INMD has a market cap of 819.7M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while INMD trades at $14.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas INMD's P/E ratio is 9.90. In terms of profitability, QSI's ROE is -0.47%, compared to INMD's ROE of +0.12%. Regarding short-term risk, QSI is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for QSI.Check INMD's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, VREX has a market cap of 776.7M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while VREX trades at $18.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas VREX's P/E ratio is 19.42. In terms of profitability, QSI's ROE is -0.47%, compared to VREX's ROE of +0.05%. Regarding short-term risk, QSI is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for QSI.Check VREX's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, AHCO has a market cap of 767.3M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while AHCO trades at $5.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas AHCO's P/E ratio is 11.51. In terms of profitability, QSI's ROE is -0.47%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, QSI is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for QSI.Check AHCO's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, AVR has a market cap of 747.7M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while AVR trades at $7.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas AVR's P/E ratio is -3.96. In terms of profitability, QSI's ROE is -0.47%, compared to AVR's ROE of -0.78%. Regarding short-term risk, QSI is more volatile compared to AVR. This indicates higher risk in terms of short-term price fluctuations for QSI.Check AVR's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, CTKB has a market cap of 729.7M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while CTKB trades at $5.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas CTKB's P/E ratio is -29.93. In terms of profitability, QSI's ROE is -0.47%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, QSI is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for QSI.Check CTKB's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while SRDX trades at $42.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas SRDX's P/E ratio is -34.66. In terms of profitability, QSI's ROE is -0.47%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, QSI is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for QSI.Check SRDX's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, SSII has a market cap of 590.4M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while SSII trades at $2.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas SSII's P/E ratio is -49.17. In terms of profitability, QSI's ROE is -0.47%, compared to SSII's ROE of -0.27%. Regarding short-term risk, QSI is more volatile compared to SSII. This indicates higher risk in terms of short-term price fluctuations for QSI.Check SSII's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while APEN trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas APEN's P/E ratio is -9.43. In terms of profitability, QSI's ROE is -0.47%, compared to APEN's ROE of -0.85%. Regarding short-term risk, QSI is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for QSI.Check APEN's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, KIDS has a market cap of 579.2M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while KIDS trades at $22.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas KIDS's P/E ratio is -19.11. In terms of profitability, QSI's ROE is -0.47%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, QSI is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for QSI.Check KIDS's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, DCTH has a market cap of 538.5M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while DCTH trades at $15.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas DCTH's P/E ratio is 1560.00. In terms of profitability, QSI's ROE is -0.47%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, QSI is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for QSI.Check DCTH's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while ZIMV trades at $18.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, QSI's ROE is -0.47%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, QSI is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for QSI.Check ZIMV's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, CERS has a market cap of 528M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while CERS trades at $2.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas CERS's P/E ratio is -87.04. In terms of profitability, QSI's ROE is -0.47%, compared to CERS's ROE of -0.10%. Regarding short-term risk, QSI is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for QSI.Check CERS's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, TCMD has a market cap of 512.7M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while TCMD trades at $22.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas TCMD's P/E ratio is 21.05. In terms of profitability, QSI's ROE is -0.47%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, QSI is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for QSI.Check TCMD's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, PACB has a market cap of 503.2M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while PACB trades at $1.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas PACB's P/E ratio is -3.95. In terms of profitability, QSI's ROE is -0.47%, compared to PACB's ROE of -49.62%. Regarding short-term risk, QSI is more volatile compared to PACB. This indicates higher risk in terms of short-term price fluctuations for QSI.Check PACB's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, SGHT has a market cap of 485.9M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while SGHT trades at $8.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas SGHT's P/E ratio is -15.95. In terms of profitability, QSI's ROE is -0.47%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, QSI is more volatile compared to SGHT. This indicates higher risk in terms of short-term price fluctuations for QSI.Check SGHT's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, NPCE has a market cap of 479.4M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while NPCE trades at $14.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas NPCE's P/E ratio is -24.67. In terms of profitability, QSI's ROE is -0.47%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, QSI is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for QSI.Check NPCE's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, CLPT has a market cap of 444.7M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while CLPT trades at $14.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas CLPT's P/E ratio is -12.57. In terms of profitability, QSI's ROE is -0.47%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, QSI is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for QSI.Check CLPT's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, SENS has a market cap of 417.9M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while SENS trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas SENS's P/E ratio is -4.48. In terms of profitability, QSI's ROE is -0.47%, compared to SENS's ROE of -1.66%. Regarding short-term risk, QSI is more volatile compared to SENS. This indicates higher risk in terms of short-term price fluctuations for QSI.Check SENS's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, OFIX has a market cap of 381.6M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while OFIX trades at $9.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas OFIX's P/E ratio is -6.15. In terms of profitability, QSI's ROE is -0.47%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, QSI is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for QSI.Check OFIX's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, CV has a market cap of 332.3M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while CV trades at $6.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas CV's P/E ratio is -10.56. In terms of profitability, QSI's ROE is -0.47%, compared to CV's ROE of -1.78%. Regarding short-term risk, QSI is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for QSI.Check CV's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while SMLR trades at $20.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas SMLR's P/E ratio is 3.92. In terms of profitability, QSI's ROE is -0.47%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, QSI is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for QSI.Check SMLR's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, RCEL has a market cap of 294.1M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while RCEL trades at $11.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas RCEL's P/E ratio is -8.22. In terms of profitability, QSI's ROE is -0.47%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, QSI is more volatile compared to RCEL. This indicates higher risk in terms of short-term price fluctuations for QSI.Check RCEL's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, TMCI has a market cap of 291.9M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while TMCI trades at $4.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas TMCI's P/E ratio is -4.79. In terms of profitability, QSI's ROE is -0.47%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, QSI is more volatile compared to TMCI. This indicates higher risk in terms of short-term price fluctuations for QSI.Check TMCI's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, CATX has a market cap of 286.3M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while CATX trades at $2.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas CATX's P/E ratio is -1.89. In terms of profitability, QSI's ROE is -0.47%, compared to CATX's ROE of -0.42%. Regarding short-term risk, QSI is more volatile compared to CATX. This indicates higher risk in terms of short-term price fluctuations for QSI.Check CATX's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, TLSI has a market cap of 267.2M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while TLSI trades at $4.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas TLSI's P/E ratio is -2.58. In terms of profitability, QSI's ROE is -0.47%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, QSI is more volatile compared to TLSI. This indicates higher risk in terms of short-term price fluctuations for QSI.Check TLSI's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, INFU has a market cap of 257.3M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while INFU trades at $12.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas INFU's P/E ratio is 31.10. In terms of profitability, QSI's ROE is -0.47%, compared to INFU's ROE of +0.15%. Regarding short-term risk, QSI is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for QSI.Check INFU's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while MGRM trades at $6.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas MGRM's P/E ratio is -12.00. In terms of profitability, QSI's ROE is -0.47%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, QSI is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for QSI.Check MGRM's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, ELMD has a market cap of 231.4M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while ELMD trades at $27.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas ELMD's P/E ratio is 21.34. In terms of profitability, QSI's ROE is -0.47%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, QSI is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for QSI.Check ELMD's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while NVRO trades at $5.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas NVRO's P/E ratio is -1.91. In terms of profitability, QSI's ROE is -0.47%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, QSI is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for QSI.Check NVRO's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, PROF has a market cap of 209.3M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while PROF trades at $5.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas PROF's P/E ratio is -5.88. In terms of profitability, QSI's ROE is -0.47%, compared to PROF's ROE of -0.56%. Regarding short-term risk, QSI is more volatile compared to PROF. This indicates higher risk in terms of short-term price fluctuations for QSI.Check PROF's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, RXST has a market cap of 192.9M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while RXST trades at $4.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas RXST's P/E ratio is -4.12. In terms of profitability, QSI's ROE is -0.47%, compared to RXST's ROE of -0.17%. Regarding short-term risk, QSI is more volatile compared to RXST. This indicates higher risk in terms of short-term price fluctuations for QSI.Check RXST's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while BSGM trades at $6.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas BSGM's P/E ratio is -5.81. In terms of profitability, QSI's ROE is -0.47%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, QSI is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for QSI.Check BSGM's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, STIM has a market cap of 190.7M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while STIM trades at $2.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas STIM's P/E ratio is -6.23. In terms of profitability, QSI's ROE is -0.47%, compared to STIM's ROE of -1.51%. Regarding short-term risk, QSI is more volatile compared to STIM. This indicates higher risk in terms of short-term price fluctuations for QSI.Check STIM's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while MDGS trades at $2.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas MDGS's P/E ratio is -0.27. In terms of profitability, QSI's ROE is -0.47%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, QSI is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for QSI.Check MDGS's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, FOCL has a market cap of 176.5M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while FOCL trades at $4.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas FOCL's P/E ratio is -4.55. In terms of profitability, QSI's ROE is -0.47%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, QSI is more volatile compared to FOCL. This indicates higher risk in terms of short-term price fluctuations for QSI.Check FOCL's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while QIPT trades at $3.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas QIPT's P/E ratio is -15.87. In terms of profitability, QSI's ROE is -0.47%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, QSI is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for QSI.Check QIPT's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, LUCD has a market cap of 157.6M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while LUCD trades at $0.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas LUCD's P/E ratio is -2.23. In terms of profitability, QSI's ROE is -0.47%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, QSI is more volatile compared to LUCD. This indicates higher risk in terms of short-term price fluctuations for QSI.Check LUCD's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, QTRX has a market cap of 154M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while QTRX trades at $3.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas QTRX's P/E ratio is -1.29. In terms of profitability, QSI's ROE is -0.47%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, QSI is more volatile compared to QTRX. This indicates higher risk in terms of short-term price fluctuations for QSI.Check QTRX's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, INGN has a market cap of 145.1M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while INGN trades at $5.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas INGN's P/E ratio is -5.89. In terms of profitability, QSI's ROE is -0.47%, compared to INGN's ROE of -0.13%. Regarding short-term risk, QSI is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for QSI.Check INGN's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while ICAD trades at $3.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas ICAD's P/E ratio is -20.37. In terms of profitability, QSI's ROE is -0.47%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, QSI is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for QSI.Check ICAD's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, ECOR has a market cap of 100.3M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while ECOR trades at $11.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas ECOR's P/E ratio is -6.62. In terms of profitability, QSI's ROE is -0.47%, compared to ECOR's ROE of +5.25%. Regarding short-term risk, QSI is more volatile compared to ECOR. This indicates higher risk in terms of short-term price fluctuations for QSI.Check ECOR's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while HJLI trades at $10.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas HJLI's P/E ratio is N/A. In terms of profitability, QSI's ROE is -0.47%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, QSI is more volatile compared to HJLI. This indicates higher risk in terms of short-term price fluctuations for QSI.Check HJLI's competition here

Quantum-Si incorporated (NASDAQ: QSI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QSI stands at 165M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, QSI is priced at $0.83 on the NASDAQ, while ASXC trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QSI currently has a P/E ratio of -1.81, whereas ASXC's P/E ratio is -1.12. In terms of profitability, QSI's ROE is -0.47%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, QSI is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for QSI.Check ASXC's competition here